Papillary serous carcinoma arising from adenomyosis presenting as intramural leiomyoma

Archives of Iranian medicine · 2007 · vol. 10(2) , pp. 258–60 · doi:07102/aim.0026 · PMID:17367236
Case report public-domain-us
View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This paper describes a rare case of papillary serous carcinoma originating from adenomyosis in a 61-year-old woman who had received tamoxifen treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Adenocarcinoma arising from adenomyosis uteri is rare. Herein, we reported a patient with papillary serous carcinoma arising from adenomyosis. The patient was a 61-year-old woman who received tamoxifen for treatment of her breast cancer over the past five years. In hysterectomy specimen taken for investigating her uncontrolled bleeding with suspicion of uterine myoma, multiple adenomyotic foci were found in the uterine wall. In one of these foci, papillary serous carcinoma was found. No evidence of tumor was seen in endometrial surface, peritoneum, and both adnexa.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Carcinoma, Papillary Endometriosis Leiomyoma Myometrium Uterine Neoplasms Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Atrophy Atrophy Breast Neoplasms Breast Neoplasms Breast Neoplasms Carcinoma, Papillary Carcinoma, Papillary Endometriosis Endometriosis Female Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-24T06:12:55.650802+00:00
pubmed
last seen: 2026-10-08T21:04:17.981133+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine